Are COVID infections continuing to rise? Multiplex Real time PCR Kit for SARS-CoV-2 Influenza A Influenza B RSV provide support

2025-05-29

      Recently, the World Health Organization announced that the COVID-19 pandemic is on the rise in parts of West Africa, Central America and the Caribbean, Eastern Europe, Southern Europe, and Western Asia.All kinds of respiratory diseases have once again come into people's attention.

    In the 14th-18th week of 2025 (March 31-May 4), the Chinese Center for Disease Control and Prevention released the results of various types of respiratory pathogens, and the results showed that the positive rate of novel coronavirus nucleic acid tests showed an upward trend this month, and the positive rate of novel coronavirus nucleic acid tests gradually increased from 7.5% in the 14th week to 8.8%, 11.1%, 13.4%, and 16.2%, showing a gradual upward trend.

    At the same time, respiratory syncytial virus and influenza A and B infections have also shown varying degrees of increase. In response to this situation, Uni-medica respiratory quad test can effectively assist clinical settings in completing rapid nucleic acid testing and facilitate accurate and swift detection.

    This test not only solves the problem of insufficient sensitivity of immunological methods, but also solves the problem of the timeliness of traditional nucleic acid detection, and can better serve the outpatient and emergency patients in the context of the high incidence of respiratory virus infection, which has been widely recognized and recommended by the expert group.

     According to the epidemiology of the pathogen spectrum and the degree of disease burden in children's outpatient and emergency departments, Shenzhen Uni-medica has selected four viruses with high incidence and high disease burden, including influenza A, influenza B, SARS-CoV-2 and respiratory syncytial virus, and nucleic acid detection adopts high-efficiency polymerase and extraction-free nucleic acid detection technologies to achieve rapid nucleic acid testing that can be adapted to conventional PCR instruments, which not only greatly shortens the detection time, but also greatly shortens the detection cost, and completes the nucleic acid amplification detection in 30 minutes for outpatient and emergency patients, providing accurate etiological detection results for outpatient and emergency patients. Provide more precise treatment strategies.